Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Sponsors and Collaborators
Chronic Lymphocytic Leukemia Research Consortium


Continue Reading

Celgene Corporation

Contact
Mary Carpenter, CRC

858-822-5635

[email protected]

Danelle F James, MD

858-822-7894

[email protected]

Principal Investigators
Thomas J Kipps, MD, PhD

Director of the CLL Research Consortium and University of California San Diego
 
Danelle F James, MD, MAS
CLL Research Consortium and University of California San Diego
 
ClinicalTrials.gov Identifier
NCT01199575